Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patients' age: An exploratory sub‐analysis of the ABPARO trial

AIM: The aim was to identify benefit thresholds for clinical variables. We hypothesize, if variables fall below or exceed these threshold levels, systemic amoxicillin/metronidazole may contribute to reducing progression of periodontitis. MATERIAL & METHODS: This is an explorative per‐protocol co...

Descripción completa

Detalles Bibliográficos
Autores principales: Eickholz, Peter, Koch, Raphael, Kocher, Thomas, Hoffmann, Thomas, Kim, Ti‐Sun, Meyle, Joerg, Kaner, Doğan, Schlagenhauf, Ulrich, Harmsen, Dag, Harks, Inga, Ehmke, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Periodontal Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594242/
https://www.ncbi.nlm.nih.gov/pubmed/30825384
http://dx.doi.org/10.1111/jcpe.13096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594242/
https://www.ncbi.nlm.nih.gov/pubmed/30825384
http://dx.doi.org/10.1111/jcpe.13096

Ejemplares similares